Pathogen Prevalence and Antimicrobial Susceptibility among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012-2013)

Clinical Therapeutics

Volumn 38, Issue 6, 2016, Pages 1510-1521

  Zalacain, Magdalena ^a   Biedenbach, Douglas J ^a   Badal, Robert E ^a   Young, Katherine ^b   Motyl, Mary ^b   Sahm, Daniel F ^a  

^a International Health Management Associates   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

adult patients; antimicrobial resistance; intra abdominal infection; surveillance; United States

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; BETA LACTAMASE;

ABDOMINAL INFECTION; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; UNITED STATES; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMANS; INTRAABDOMINAL INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; UNITED STATES;

EID: 84971657464     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2016.04.035     Document Type: Article

References (28)

1. F. Menichetti, and G. Sganga Definition and classification of intra-abdominal infections J Chemother 21 Suppl 1 2009 3 4
2. M. Sartelli, F. Catena, L. Ansaloni, and et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study World J Emerg Surg 9 2014 37
3. S. Deresinski Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data Clin Infect Dis 45 Suppl 3 2007 S177 S183
4. A. Fraser, M. Paul, N. Almanasreh, and et al. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay Am J Med 119 2006 970 976
5. D.M. Shlaes, D.N. Gerding, J.F. John Jr, and et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals Clin Infect Dis 25 1997 584 599
6. D.L. Paterson Resistance in gram-negative bacteria: Enterobacteriaceae Am J Med 119 2006 S20 S28 discussion S62-70
7. J.S. Solomkin, J.E. Mazuski, J.S. Bradley, and et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Clin Infect Dis 50 2010 133 164
8. M.E. Falagas, and D.E. Karageorgopoulos Extended-spectrum beta-lactamase-producing organisms J Hosp Infect 73 2009 345 354
9. D.J. Hoban, S.K. Bouchillon, S.P. Hawser, and et al. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007 Diagn Microbiol Infect Dis 66 2010 78 86
10. S.P. Hawser, S.K. Bouchillon, D.J. Hoban, and et al. Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study Surg Infect (Larchmt) 11 2010 371 378
11. R.H. Dhillon, and J. Clark ESBLs: a clear and present danger? Crit Care Res Pract 2012 625170
12. J.M. Rodriguez-Martinez, M.E. Cano, C. Velasco, and et al. Plasmid-mediated quinolone resistance: an update J Infect Chemother 17 2011 149 182
13. Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 9th ed. Approved standard M07-A9 2012 Clinical and Laboratory Standards Institute Wayne, Pa, USA
14. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; Twenty-third Informational Supplement, in M100-S24 2014 Clinical Laboratory Standards Institute Wayne, PA, USA
15. D.J. Hoban, S.K. Bouchillon, S.P. Hawser, and et al. Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) Antimicrob Agents Chemother 54 2010 3031 3034
16. D.J. Hoban, R. Badal, S. Bouchillon, and et al. In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011 Diagn Microbiol Infect Dis 9 2014 367 372
17. T. Babinchak, R. Badal, D. Hoban, and et al. Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010 Diagn Microbiol Infect Dis 76 2013 379 381
18. I. Morrissey, M. Hackel, R. Badal, and et al. A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011 Pharmaceuticals (Basel) 6 2013 1335 1346
19. S.P. Hawser, S.K. Bouchillon, C. Lascols, and et al. Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates Antimicrob Agents Chemother 55 2011 3917 3921
20. H. Yigit, A.M. Queenan, G.J. Anderson, and et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae Antimicrob Agents Chemother 45 2001 1151 1161
21. R.S. Arnold, K.A. Thom, S. Sharma, and et al. Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria South Med J 104 2011 40 45
22. L. Ma, C.J. Lin, J.H. Chen, and et al. Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases Antimicrob Agents Chemother 53 2009 104 111
23. S.N. Peerayeh, E. Rostami, S.D. Siadat, and et al. High rate of aminoglycoside resistance in CTX-M-15 producing Klebsiella pneumoniae isolates in Tehran, Iran Lab Med 45 2014 231 237
24. H.S. Sader, D.J. Farrell, R.K. Flamm, and et al. Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012) Antimicrob Agents Chemother 58 2014 2274 2280
25. J.S. Lewis 2nd, M. Herrera, B. Wickes, and et al. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system Antimicrob Agents Chemother 51 2007 4015 4021
26. S.P. Hawser, S.K. Bouchillon, D.J. Hoban, and et al. Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007 Antimicrob Agents Chemother 53 2009 3280 3284
27. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, in M100-S20 2010 Clinical Laboratory Standards Institute Wayne, PA, USA
28. R.P. Rennie, and R.N. Jones Effects of breakpoint changes on carbapenem susceptibility rates of Enterobacteriaceae: results from the SENTRY Antimicrobial Surveillance Program, United States, 2008 to 2012 Can J Infect Dis Med Microbiol 25 2014 285 287